Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11027892rdf:typepubmed:Citationlld:pubmed
pubmed-article:11027892lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:11027892lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:11027892lifeskim:mentionsumls-concept:C0011209lld:lifeskim
pubmed-article:11027892lifeskim:mentionsumls-concept:C0814470lld:lifeskim
pubmed-article:11027892lifeskim:mentionsumls-concept:C0557854lld:lifeskim
pubmed-article:11027892lifeskim:mentionsumls-concept:C0679841lld:lifeskim
pubmed-article:11027892pubmed:issue3lld:pubmed
pubmed-article:11027892pubmed:dateCreated2000-11-20lld:pubmed
pubmed-article:11027892pubmed:abstractTextThis study examined services received for HIV risk reduction among individuals in drug treatment. Analyses were conducted using data from 4,412 participants in the national Drug Abuse Treatment Outcome Study (DATOS), a prospective multisite study of drug treatment effectiveness. A higher percentage of individuals in long-term residential programs received HIV-related services, compared with clients in short-term inpatient, methadone maintenance, and outpatient drug-free programs. More men than women, and individuals at higher sex-risk as compared with those at lower sex-risk, received HIV services. Logistic regression analyses indicated that individuals who engaged in sex work had a higher likelihood than those who did not, of receiving HIV-related services, although individuals with high-risk or multiple sexual partners were no more likely than others to receive HIV services. More comprehensive service delivery is needed in order to reduce the risk for HIV among clients in drug treatment.lld:pubmed
pubmed-article:11027892pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11027892pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11027892pubmed:languageenglld:pubmed
pubmed-article:11027892pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11027892pubmed:citationSubsetIMlld:pubmed
pubmed-article:11027892pubmed:statusMEDLINElld:pubmed
pubmed-article:11027892pubmed:monthOctlld:pubmed
pubmed-article:11027892pubmed:issn0740-5472lld:pubmed
pubmed-article:11027892pubmed:authorpubmed-author:JoshiVVlld:pubmed
pubmed-article:11027892pubmed:authorpubmed-author:AnglinM DMDlld:pubmed
pubmed-article:11027892pubmed:authorpubmed-author:GrellaC ECElld:pubmed
pubmed-article:11027892pubmed:authorpubmed-author:EtheridgeR...lld:pubmed
pubmed-article:11027892pubmed:issnTypePrintlld:pubmed
pubmed-article:11027892pubmed:volume19lld:pubmed
pubmed-article:11027892pubmed:ownerNLMlld:pubmed
pubmed-article:11027892pubmed:authorsCompleteYlld:pubmed
pubmed-article:11027892pubmed:pagination229-37lld:pubmed
pubmed-article:11027892pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:meshHeadingpubmed-meshheading:11027892...lld:pubmed
pubmed-article:11027892pubmed:year2000lld:pubmed
pubmed-article:11027892pubmed:articleTitleDelivery of HIV risk-reduction services in drug treatment programs.lld:pubmed
pubmed-article:11027892pubmed:affiliationDrug Abuse Research Center, Neuropsychiatric Institute, University of California, Los Angeles, 1640 S. Sepulveda Boulevard, Suite 200, Los Angeles, CA 900025, USA. grella@ucla.edulld:pubmed
pubmed-article:11027892pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11027892pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11027892pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11027892pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11027892lld:pubmed